Human B cell interleukin 10

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Interleukin 10 (IL-10) is a lymphokine with sequence homology to Epstein-Barr virus (EBV) open reading frame BCRF1.
• EBV-positive B cell lines from AIDS and Burkitt's lymphoma patients secrete significantly more IL-10 than other EBV-positive B cell lines.
• EBV-negative B cell lines do not express IL-10.

Purpose of the Study:

• To investigate the role of IL-10 in B cell lymphomas, particularly in the context of EBV and HIV-1 infections.
• To determine the relationship between IL-10 production and B cell differentiation stages.
• To explore the potential involvement of IL-10 and BCRF1 in the pathophysiology of non-Hodgkin's lymphomas.

Main Methods:

• Analysis of IL-10 secretion in various EBV-positive and EBV-negative B cell lines using Northern blot, ELISA, and PCR.
• Investigation of IL-10 production in B cells at different differentiation stages.
• Experimental infection of tonsillar B cells with EBV to assess IL-10 secretion.
• Correlation of IL-10 levels with HIV-1 infection in AIDS-related lymphomas.

Main Results:

• EBV-positive B cell lines from AIDS and Burkitt's lymphoma patients exhibited high IL-10 secretion.
• IL-10 expression was restricted to mature and pre-plasmacytic B cell stages, not detected in earlier or myeloma cells.
• EBV infection directly induced IL-10 secretion in tonsillar B cells.
• Elevated IL-10 in AIDS-related lymphomas suggests a role for HIV-1 in its secretion.

Conclusions:

• B cell IL-10 is implicated in the pathogenesis of non-Hodgkin's lymphomas.
• IL-10 may act as an autocrine growth factor for B cell lymphomas.
• Both IL-10 and the EBV-encoded BCRF1 protein appear to play roles in non-Hodgkin's lymphoma development.